Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
None listed
Sponsors
Dr Urvashi
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinical features of Yakritudara (NAFLD) such as daurbalya (fatigue), aruchi (loss of appetite), constipation, hrillasa (nausea), anaha (flatulence), and udara shoola (abdominal pain), along with elevated liver enzymes (SGOT/AST and SGPT/ALT) and ultrasonographic evidence of Grade I or Grade II fatty liver will be included in the study. Patients with controlled diabetes mellitus having Grade I or Grade II fatty liver will also be included.
Exclusion criteria
Exclusion criteria: Patients those suffering from chronic renal failure, ischemic heart disease, congestive cardiac failure, liver cirrhosis, or AIDS, patients with Grade III fatty liver, pregnant or lactating women, and individuals with hepatitis B, hepatitis C, autoimmune hepatitis, drug-induced hepatitis, or alcoholic hepatitis will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in the signs and symptoms of Yakritudara/NAFLD, mainly Daurbalya, Aruchi, Constipation, Hrillasa, Anaha and Udara Shoola, along with improvement in objective parameters.Timepoint: Baseline (Day 0), after treatment/end of study (Day 30), and follow-up on Day 16 and Day 30. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in LFT, lipid profile and USG abdomen grading.Timepoint: Baseline and end of treatment/follow-up period. | — |
Countries
India
Contacts
Public ContactDr Urvashi
Himalayiya Ayurvedic PG Medical College
Outcome results
None listed